| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP1392355A1 Use of proteasome inhibitors to treat dry eye disorders |
| 03/03/2004 | EP1392328A2 Cancer therapy |
| 03/03/2004 | EP1392288A2 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus |
| 03/03/2004 | EP1392204A2 Bifunctional energy-reversible acyl-compositions |
| 03/03/2004 | EP1076645B1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino) -2-oxopyrr olidin-1-yl]propionate |
| 03/03/2004 | EP0929217B1 Sordarin derivatives |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
| 03/02/2004 | US6699990 Colorfastness; waterproofing; oxidative color hair dyes |
| 03/02/2004 | US6699988 By reacting phosgene and lactam in the presence of a non-nucleophilic aliphatic tertiary amine, such as n,n-diisopropylethylamine; high purity, good yields |
| 03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699881 Thiol compounds, their production and use |
| 03/02/2004 | US6699818 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 03/02/2004 | US6699651 Base precursors for use in a photothermographic element |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 03/02/2004 | CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/26/2004 | WO2004016588A1 Furanone derivatives and methods of making same |
| 02/26/2004 | WO2004016587A1 Nitrogen-containing compounds |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2003029495A3 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 02/26/2004 | US20040039211 Tetrapyrroles |
| 02/26/2004 | US20040039182 Mono-and bis-hydrazone pigments |
| 02/26/2004 | US20040039064 Treating and/or preventing alzheimer's disease and other neurodegenerative diseases; beta-secretase inhibitors |
| 02/26/2004 | US20040039053 Administering to a patient a (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives or salt, free of its (+) stereoisomer to treat the type II diabetes, gout, insulin resistance and atherosclerosis |
| 02/26/2004 | US20040039044 Coupling under reducing conditions aminoalkylpyrrolidine-n-alkyl with one equivalant of a aldehyde compound; useful for treating pain, schizophrenia, depression and sleep disorders |
| 02/26/2004 | US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 02/26/2004 | US20040039038 Biaromatic compound activators of PPARy-type receptors |
| 02/26/2004 | US20040038958 Topical treatment of skin diseases |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/26/2004 | US20040037802 Activated polymeric bicine derivatives such as polypeptides modified with these polymers exhibit reduced immunogenicity/antigenicity and circulate in the blood |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/26/2004 | US20040035293 Melt point is < 100 degrees c; provides distinct selectivities and reactivities because they are made of ions rather than molecules |
| 02/26/2004 | DE20215415U1 Wasserlösliche Medikamentenvorstufen von Propofol Water-soluble prodrugs of propofol |
| 02/26/2004 | DE10236868A1 New (hetero)aryl-substituted carboxamide compounds, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors |
| 02/26/2004 | CA2495784A1 Furanone derivatives and methods of making same |
| 02/26/2004 | CA2495383A1 Fused benzene derivative and use |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391453A1 Pyroglutamic acid salt of amlodipine |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1391450A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 02/25/2004 | EP1390361A2 Melanocortin receptor ligands |
| 02/25/2004 | EP1390357A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 02/25/2004 | EP1390347A1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 02/25/2004 | EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/25/2004 | EP1087934B1 Aminocyclohexyl ether compounds and uses thereof |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | EP0981526B1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1477947A Primary intermediates for oxidative coloration of hair |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/24/2004 | US6695969 Displacement chromatography and involves using a displacer for displacing the hmg-coa reductase inhibitor |
| 02/24/2004 | CA2208141C Fungicidal mixture |
| 02/19/2004 | WO2004015164A1 Pyrrolyl complexes of copper for copper metal deposition |
| 02/19/2004 | WO2004014896A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014425A1 Activators of small conductance calcium activated potassium channels and use thereof |
| 02/19/2004 | WO2004014424A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 02/19/2004 | WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators |
| 02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 02/19/2004 | US20040034236 Converting a protected 1,4- dihydroxy-2-amino or protected amino butane in presence of hydroxylamine or an acid additon salt into N-hydroxy-pyrrolidone derivative, reducting N-hydroxy group to secondary amine by hydrogenation |
| 02/19/2004 | US20040034235 Cyclization method for the synthesis of pyrrolidine derivative compounds |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | US20040034229 3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists |
| 02/19/2004 | US20040034202 Ketone spirocyclopropaneindene compounds; antineoplastic agents to inhibit tumor cell growth in vitro or in vivo; particularly effective against solid tumors and multi-drug resistant tumors |
| 02/19/2004 | US20040034189 Polypyrrole homo- or copolymers, polyphenyl resins, aromatic resins; used as electroluminescence element, light emitting diodes, detector, module, waveguide, transistor, laser, light-absorbing body, dielectric substance, membrane |
| 02/19/2004 | US20040034080 Comprises catalytic hydroformylation/hydrocarbonylation and reductive amination using a transition metal catalyst |
| 02/19/2004 | US20040034063 Antiallergens for treating and prevention of asthma |
| 02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040034019 Piperazine and piperidine derivatives |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/19/2004 | US20040034011 Administering to a mammal a napthalene derivative containing at least two hydroxy groups at ortho position to one another, for the treatment of disorders caused by catechol-O-methyltransferase enzyme |
| 02/19/2004 | US20040033934 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof |
| 02/19/2004 | US20040033514 Detection of disease related genes |
| 02/19/2004 | DE10236340A1 New heteroar(alkan)oyl-substituted phenyl-beta-alaninamide derivatives, useful as broad-spectrum antibacterial agents in human or veterinary medicine |
| 02/19/2004 | CA2494269A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389626A1 Aromatic copolymers of pyrroles and an electroluminescent element using the same |
| 02/18/2004 | EP1389611A1 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/18/2004 | EP1389460A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound |
| 02/18/2004 | EP1389305A2 Peptide fragmentation |
| 02/18/2004 | EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 02/18/2004 | EP1216248B1 Triazolopyrimidine derivatives |
| 02/18/2004 | EP1213281B1 Novel amide derivatives |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |